GIP / GLP-1 · check the device

Tirzepatide prices.

See compounded program prices beside separately labeled Zepbound offers. Memberships, dose bands and refill deadlines can change the bill.

9 listed offers6 providers / brandsChecked October 8, 2026

Inspect the terms, then compare

Published offers.

8 offers shown

Sorting compares displayed numbers only. Billing units, routes, supply periods and included services can differ. Featured placements above are separate.

O
OrderlyMedsInjection · Compounded prescription

Three-month tirzepatide starter

Compounded prescription

New-patient starter offer: $449 for three months, paid upfront. Published standard monthly price afterward is $299. Starter eligibility and the prescribed plan must be confirmed.

$149.67/mo equivalent$449 upfrontRead the breakdown →
iV
Ivím HealthInjection · Compounded prescription

Compounded tirzepatide program

Compounded prescription

Advertised starting price includes medication and program fee. Program duration determines prescribing and shipping; the page says cancellation is unavailable once the program starts.

L
Lilly / LillyDirectInjection · FDA-approved medicine

Zepbound KwikPen 2.5 mg

FDA-approved medicine

Self-pay KwikPen offer. Higher strengths at $449 require refill purchase within 45 days to retain the offer; regular prices are $499 for 7.5 mg and $699 for 10–15 mg. Eligibility and taxes or fees may apply.

L
Lilly / LillyDirectInjection · FDA-approved medicine

Zepbound KwikPen 5 mg

FDA-approved medicine

Self-pay KwikPen offer. Higher strengths at $449 require refill purchase within 45 days to retain the offer; regular prices are $499 for 7.5 mg and $699 for 10–15 mg. Eligibility and taxes or fees may apply.

L
Lilly / LillyDirectInjection · FDA-approved medicine

Zepbound KwikPen 7.5–15 mg

FDA-approved medicine

Self-pay KwikPen offer. Higher strengths at $449 require refill purchase within 45 days to retain the offer; regular prices are $499 for 7.5 mg and $699 for 10–15 mg. Eligibility and taxes or fees may apply.

What this board can tell you.

Zepbound is an FDA-approved tirzepatide medicine. Its approved uses and contraindications are defined in its prescribing information. A compounded preparation has not undergone FDA approval. Manufacturer offers for one device cannot be assumed to apply to another device or to every insurance situation.

Sources: Zepbound — prescribing information, FDA — concerns with unapproved GLP-1 drugs

Follow the evidence

Sources & price notes

Checked October 8, 2026. Provider pages document advertised terms; they do not independently establish clinical outcomes.

  1. Zepbound — prescribing information ↗

    Approved uses, contraindications and warnings.

  2. FDA — concerns with unapproved GLP-1 drugs ↗

    Safety, dosing errors, salt forms and misleading online marketing.

  3. CoreAge Rx — Compounded tirzepatide ↗

    Official public information; price and terms checked October 8, 2026.

  4. CoreAge Rx — product and plan terms ↗

    Official public information; price and terms checked October 8, 2026.

  5. FDA — compounding questions and answers ↗

    Clinical and regulatory context. A compounded preparation is not FDA-approved.

  6. OrderlyMeds — full pricing ↗

    Official public information; price and terms checked October 8, 2026.

  7. Mochi Health — pricing FAQ ↗

    Official public information; price and terms checked October 8, 2026.

  8. Ivím — individualized GLP-1 program ↗

    Official public information; price and terms checked October 8, 2026.

  9. Ro — membership and medication prices ↗

    Official public information; price and terms checked October 8, 2026.

  10. Lilly — Zepbound self-pay and savings terms ↗

    Official public information; price and terms checked October 8, 2026.